IMU

9.26%

5.9¢ imugene limited

Media Thread, page-12579

First 12579 Last

Share
Profile

Follow
kingkev

27,480 Posts.

1299

22/03/24

08:03

Post #: 73005568
Share

Originally posted by Taureanbull: ↑

Hawkbar, The company doesn’t need to arrive at its final destination for the share price to move. As I have pointed out several times, the company does want to move onto the NASDAQ. It does have major international investors watching the OASIS trial closely. The company has also employed a corporate strategist.. A lot of money has already been spent preparing for a NASDAQ listing. And we have several trial results for our platforms being released this year.

The stock market is very cable of relating a stock without seeing a big pharma deal. This company has made incredible progress in the last two years. At some stage this progress will be reflected in the share price, Whilst it may seem like it’s sat idle forever this does not predict forward shareprice movement. As with the big effort to push our clinical programs ahead, after we get the results released, the company will use these results as a catalyst to push our ahead our corporate strategy and the share price will respond accordingly.

There is a reason we are seeing this flurry of media activity. Did you also note in the last video of Leslie Chong, mentioned “ a recent presentation to US investors”. Whilst we haven’t seen a video, posted here and do not have any further information, it does hint that she is presenting to them. And it’s unlikely to be Mums and Dads . The US has a quite large and sophisticated BIOTECH focussed investment community. As opposed to Australia that has a very thin sprinkling of mums and dads.

It’s very much my experience that the SP,of a successful Biotexh will rerate rapidly when institutional investors come on board . This hasn’t happened to IMU as yet, in part because dour domestic fund managers don’t touch Biotexh. But US investors have a huge appetite for future disruptive technologies.

And that is exactly what IMU is about to unveil. The results of trials . That’s is why they dumped ALA , because our drugs are so good they don’t need ALA. All of this has been presented in the 4 videos and assorted other social media posts and announcements.

I personally got a lot from Dr Bradley Glovers presentation. And further as I shared with this board, I was lucky enough to have the opportunity to meet him and ask why he joined IMU. He reinforced his reasons again yesterday.

As he is a highly qualified expert on Celular Therapies , I’m very happy to take his word , that we have an amazing portfolio of assets here, And I’m happy to trust that major investors will see this opportunity resulting in a major relating of our share price.A Market Cap of just US$520M is clearly ridiculously low.

Expand

all good and in the meantime we hope we can hold on to 11c

IMU Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Bitcoin investors need to know the risks

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

ASX hits all time high out the gate on Friday trades following bullish US inflation data

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

There are more pages in this discussion • 2,080 more messages in this thread...

First 12579 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.9¢		Change 0.005(9.26%)		Mkt cap ! $433.6M

Open	High	Low	Value	Volume
5.5¢	5.9¢	5.4¢	$1.489M	25.99M

Buyers (Bids)

No.	Vol.	Price($)
2	35252	5.9¢

Sellers (Offers)

Price($)	Vol.	No.
6.0¢	1753430	24

View Market Depth

No.	Vol.	Price($)
2	35252	0.059
3	727241	0.058
14	2231166	0.057
5	2211114	0.056
22	2671091	0.055

Price($)	Vol.	No.
0.060	1753430	24
0.061	663559	7
0.062	305000	5
0.063	100000	1
0.064	304500	4

Last trade - 16.10pm 12/07/2024 (20 minute delay)

IMU (ASX) Chart

Media Thread, page-12579

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Bitcoin investors need to know the risks

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nimy to raise $1.21M to explore 'newsy' WA targets

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Immutep reports strong response rate from immunotherapies treating carcinomas

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media Thread, page-12579

Top Stories

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Bitcoin investors need to know the risks

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Nimy to raise $1.21M to explore 'newsy' WA targets

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Immutep reports strong response rate from immunotherapies treating carcinomas

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News